Predictor | Category/unit | Univariable | Multivariable | ||||||
B | 95% CI | P value | B | 95% CI | Tolerance | VIF | P value | ||
Year | 1 year | 0.07 | (−0.22 to 0.36) | 0.632 | |||||
No of authors | 1 person | 0.10 | (0.02 to 0.18) | 0.019 | 0.05 | (−0.03 to 0.13) | 0.87 | 1.15 | 0.216 |
Continent | North America | Reference | |||||||
Europe | 0.74 | (−0.08 to1.56) | 0.078 | ||||||
Oceania | 0.54 | (−0.28 to 1.36) | 0.197 | ||||||
Asia | 0.73 | (−0.37 to 1.83) | 0.191 | ||||||
South America | −0.39 | (−2.16 to 1.37) | 0.661 | ||||||
Type of Intervention | Pharmacological | Reference | Reference | ||||||
Non-pharmacological | −1.02 | (−1.53 to -0.51) | <0.001 | −0.70 | (−1.27 to to -0.12) | 0.73 | 1.37 | 0.018 | |
No of centres | Single centre | Reference | |||||||
Multicentre | 0.45 | (−0.35 to 1.25) | 0.267 | ||||||
Word count | 1 word | 0.00 | (−0.01 to 0.01) | 0.923 | |||||
Research area | Insomnia | Reference | Reference | ||||||
Sleep-related breathing disorders | 0.78 | (0.25 to 1.31) | 0.004 | 0.42 | (−0.13 to 0.97) | 0.77 | 1.30 | 0.135 | |
Others | 0.42 | (−0.19 to 1.03) | 0.179 | −0.17 | (−0.80 to 0.47) | 0.77 | 1.30 | 0.599 | |
Sample size | 1 participant | −0.001 | (−0.00 to 0.00) | 0.139 | |||||
Funded by industry | Yes | Reference | Reference | ||||||
No | −1.08 | (−1.58 to -0.58) | <0.001 | −0.66 | (−1.24 to -0.08) | 0.72 | 1.40 | 0.025 |
For multivariable analysis, constant=6.106, R2=0.153, adjusted R2=0.128, p<0.001.
VIF, variance inflation factor.
Bold values are those indicating statistical significance.